DaShenLin Pharmaceutical Group Co., Ltd.SSE: 603233

(603233)"DaShenLin Pharmaceutical Group Co., Ltd."Announcement on Progress in Providing Guarantees for Subsidiaries

· Issued by DaShenLin Pharmaceutical Group Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Stock code 603233 · · 8 pages · Chinese

Summary by 6ix AI

DaShenLin Pharmaceutical Group Co., Ltd. has announced progress in providing guarantees for its subsidiaries. The company is offering a total guarantee amount to support the operational funding needs of its subsidiaries. As of the announcement date, the total external guarantee balance stands at a significant amount, reflecting the company's commitment to its subsidiaries' financial health. The board has approved this guarantee as part of its strategic development plan, ensuring that the subsidiaries can maintain normal operations.

Written in English by 6ix AI from the company’s Chinese-language filing. How 6ix writes summaries

On 6ix: 6ix.com/news/603233dashenlin-pharmaceutical-group-co-ltdannouncement-on-progress-in-providing-guarantees-for-subsidiaries-1

Release

Announcement on Progress in Providing Guarantees for Subsidiaries
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference:

DaShenLin Pharmaceutical Group Co., Ltd. on 6ix

Story so far

Earlier from DaShenLin Pharmaceutical

Later from DaShenLin Pharmaceutical

All DaShenLin Pharmaceutical news releases